Literature DB >> 15033479

AICAR stimulates adiponectin and inhibits cytokines in adipose tissue.

Aina S Lihn1, Niels Jessen, Steen B Pedersen, Sten Lund, Bjørn Richelsen.   

Abstract

5-Aminoimidazole-4-carboxamide ribonucleoside (AICAR) can be used as an experimental tool to activate 5'-AMP-activated protein kinase (AMPK) and has been shown to improve insulin sensitivity. In parallel adiponectin also seems to activate AMPK and to improve insulin sensitivity. We have investigated the effects of AICAR on the gene expression of adiponectin and on gene expression and release of cytokines in human adipose tissue in vitro. AICAR stimulated AMPK alpha1 activity 3-4-fold (p<0.001), and dose-dependently increased adiponectin mRNA levels with significant stimulation (2-4-fold) at AICAR concentrations of 0.5-2mM (p<0.05). The adipose tissue protein release of tumor necrosis factor-alpha (TNF- alpha) and interleukin-6 (IL-6) was decreased by AICAR (p<0.05). In conclusion, AICAR stimulated adipose tissue AMPK alpha1 activity and adiponectin gene expression, while attenuating the release of TNF-alpha and IL-6. Reduced concentrations of these cytokines and increased levels of adiponectin might play a role for the insulin sensitizing effects of AICAR.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15033479     DOI: 10.1016/j.bbrc.2004.02.139

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  40 in total

1.  Effects of lipoic acid on AMPK and adiponectin in adipose tissue of low- and high-fat-fed rats.

Authors:  Pedro L Prieto-Hontoria; Patricia Pérez-Matute; Marta Fernández-Galilea; J Alfredo Martínez; María J Moreno-Aliaga
Journal:  Eur J Nutr       Date:  2012-06-05       Impact factor: 5.614

2.  Effect of exercise on the expression of adiponectin mRNA and GLUT4 mRNA in type 2 diabetic rats.

Authors:  Zhaosheng Tang; Li Yuan; Chengying Gu; Yun Liu; Lian Zhu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

3.  Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet.

Authors:  P Flachs; V Mohamed-Ali; O Horakova; M Rossmeisl; M J Hosseinzadeh-Attar; M Hensler; J Ruzickova; J Kopecky
Journal:  Diabetologia       Date:  2006-01-06       Impact factor: 10.122

Review 4.  Beyond AICA riboside: in search of new specific AMP-activated protein kinase activators.

Authors:  Bruno Guigas; Kei Sakamoto; Nellie Taleux; Sara M Reyna; Nicolas Musi; Benoit Viollet; Louis Hue
Journal:  IUBMB Life       Date:  2009-01       Impact factor: 3.885

Review 5.  Adipose-immune interactions during obesity and caloric restriction: reciprocal mechanisms regulating immunity and health span.

Authors:  Vishwa Deep Dixit
Journal:  J Leukoc Biol       Date:  2008-06-25       Impact factor: 4.962

6.  AMPK is involved in mediation of erythropoietin influence on metabolic activity and reactive oxygen species production in white adipocytes.

Authors:  Li Wang; Lijun Di; Constance Tom Noguchi
Journal:  Int J Biochem Cell Biol       Date:  2014-06-19       Impact factor: 5.085

7.  Regulation of FSP27 protein stability by AMPK and HSC70.

Authors:  Xiaodong Zhang; Bradlee L Heckmann; Xitao Xie; Alicia M Saarinen; Jun Liu
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-10-14       Impact factor: 4.310

8.  PKA phosphorylates and inactivates AMPKalpha to promote efficient lipolysis.

Authors:  Nabil Djouder; Roland D Tuerk; Marianne Suter; Paolo Salvioni; Ramon F Thali; Roland Scholz; Kari Vaahtomeri; Yolanda Auchli; Helene Rechsteiner; René A Brunisholz; Benoit Viollet; Tomi P Mäkelä; Theo Wallimann; Dietbert Neumann; Wilhelm Krek
Journal:  EMBO J       Date:  2009-11-26       Impact factor: 11.598

Review 9.  AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease.

Authors:  Aaron K F Wong; Jacqueline Howie; John R Petrie; Chim C Lang
Journal:  Clin Sci (Lond)       Date:  2009-04       Impact factor: 6.124

10.  AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol.

Authors:  Jee-Hyun Um; Sung-Jun Park; Hyeog Kang; Shutong Yang; Marc Foretz; Michael W McBurney; Myung K Kim; Benoit Viollet; Jay H Chung
Journal:  Diabetes       Date:  2009-11-23       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.